These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect in man of a new indandione anticoagulant. FIELD JB; GOLDFARB MS; WARE AG; GRIFFITH GC Proc Soc Exp Biol Med; 1952 Dec; 81(3):678-81. PubMed ID: 13037763 [No Abstract] [Full Text] [Related]
4. [Preliminary clinical investigations on a new indandione type anticoagulant: anisindione]. BALLERINI G; LA PAGLIA S Prog Med (Napoli); 1959 Jan; 15(2):46-8. PubMed ID: 13658270 [No Abstract] [Full Text] [Related]
6. [Clinical trial of a new anticoagulant: 2-(4-bromophenyl)-1,3-indandione]. BRUNE J; VERNEYRE H; DELAHAYE JP Lyon Med; 1962 Mar; 94():565-72. PubMed ID: 13873987 [No Abstract] [Full Text] [Related]
7. [Clinical studies on the coagulation-inhibiting activity of a new anticoagulant of the indandione series]. STROBEL E Arzneimittelforschung; 1962 Jul; 12():718-20. PubMed ID: 13917816 [No Abstract] [Full Text] [Related]
9. Uricosuric action of 2-phenyl-5-bromo-1,3-indandione. PASERO G; MARINI N Gazz Med Ital; 1958 Dec; 117(12):561-7. PubMed ID: 13630380 [No Abstract] [Full Text] [Related]
10. THE ANTICOAGULANT ACTION OF 2,2'-ARYLENE-BIS-INDANDIONE-1,3. GUMINSKA M; ECKSTEIN M; STACHURSKA B Farmaco Sci; 1964 Aug; 19():653-60. PubMed ID: 14180152 [No Abstract] [Full Text] [Related]
11. [RESEARCH ON THE ANTICOAGULANT ACTION OF AN INDANDIONE DERIVATIVE (ANISINDIONE) WITH PROLONGED ACTION]. GIBELLI A; DELUTTEROTTI A Rass Int Clin Ter; 1964 Jan; 44():1-8. PubMed ID: 14126507 [No Abstract] [Full Text] [Related]
12. [Change in the frequency of blocking in Xenopsylla cheopis (Aphaniptera) fleas infected with the causative agent of plague under the action of indandione blood anticoagulants]. Rudenchik IuV; Ershova LS; Shuvarikov BP; Shilova SA Parazitologiia; 1979; 13(6):589-92. PubMed ID: 583178 [No Abstract] [Full Text] [Related]
13. Clinical experience with a new anticoagulant, dipaxin (2-diphenylacetyl-1,3-indandione). PASCALE LR; OLWIN JH Circulation; 1954 Feb; 9(2):230-7. PubMed ID: 13127184 [No Abstract] [Full Text] [Related]
14. Pharmacokinetics of 2-phenyl-1,3-indandione in the rat after i.v. and oral administration. de Vries J; Verboom CN; Groot EJ; Nauta WT; Wattel E Eur J Drug Metab Pharmacokinet; 1979; 4(4):225-9. PubMed ID: 535602 [TBL] [Abstract][Full Text] [Related]
15. Long term anticoagulant therapy. A six-year study of 43an indandione derivative. RAWLS WB; CONNOR CA Am J Cardiol; 1959 Oct; 4():470-5. PubMed ID: 14436600 [No Abstract] [Full Text] [Related]
16. Dipaxin: 2-diphenylacetyl-1,3-indandione; clinical evaluation of a new anticoagulant. FIELD JB; GOLDFARB MS; WARE AG; GRIFFITH GC Circulation; 1955 Apr; 11(4):576-83. PubMed ID: 14364732 [No Abstract] [Full Text] [Related]
17. [Polarographic properties of 2-aryl derivatives of 1,3-indandione. I. Microcoulometric evaluation of 2-phenyl-1,3-indandione by electroreduction in an alkaline medium]. DANEK A Acta Pol Pharm; 1962; 19():345-9. PubMed ID: 14024881 [No Abstract] [Full Text] [Related]
18. [EXPERIENCE WITH THE USE OF INDANDIONE ANTICOAGULANTS IN MYOCARDIAL INFARCT AND STENOCARDIA]. ALUSCIN PM; SHAROVA IuA; DEMIDOVA NV Klin Med (Mosk); 1964 Jun; 42():83-5. PubMed ID: 14243265 [No Abstract] [Full Text] [Related]
19. [On the phthalides and 1,3-indaniones. XXIX. Preparation and anticoagulation activity of 2-phenyl-1,3-indandiones substituted in the position 5 of the indandione and in the position 4' of the phenyl nucleus]. Hrnciar P; Hrnciarová M; KovalcĂk V Cesk Farm; 1968 Mar; 17(3):118-21. PubMed ID: 5666301 [No Abstract] [Full Text] [Related]
20. Antiinflammatory activity of two phenylindandione derivatives. Rosini S; Trallori L Farmaco Sci; 1976 Jun; 31(6):403-11. PubMed ID: 1278360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]